Lucid Diagnostics LUCD Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $27.88M+10.6% | $34.71M+55.2% | $47.3M+226% | $31.1M+24.9% | $25.2M+1.6% | ||
| $689K+1,030% | $643K+1,329% | $550K+1,310% | $373K+133% | $61K+24.5% | ||
| $469K-3.1% | $353K+3.5% | $486K-25.3% | $505K-26.1% | $484K+18.0% | ||
| $31.36M+13.9% | $37.47M+49.0% | $49.84M+196% | $33.83M+21.1% | $27.54M-0.2% | ||
| $907K-12.8% | $809K-23.8% | $862K-8.3% | $948K-9.7% | $1.04M-16.3% | ||
| $210K-66.7% | $315K-57.2% | $421K-50.0% | $526K-44.5% | $631K-40.0% | ||
| $34.08M+3.9% | $40.45M+31.7% | $53.2M+135% | $38.67M+13.4% | $32.8M+2.3% | ||
| $1.08M+29.9% | $970K-21.8% | $751K-33.8% | $833K-7.8% | $829K-14.4% | ||
| $29.39M-19.6% | $28.58M+21.5% | $26.21M+83.9% | $29.43M+84.1% | $36.57M+83.1% | ||
| $30.08M-21.2% | $29.51M+16.5% | $27.36M+68.3% | $30.81M+69.9% | $38.17M+89.4% | ||
| $165K-99.9% | $131K+108% | $300M0.0% | $300M0.0% | $300M+50.0% | ||
| -$297.96M-24.3% | -$274.34M-34.6% | -$258.07M-34.3% | -$247.67M-37.7% | -$239.78M-42.0% | ||
| $4M+174% | $10.94M+103% | $25.84M+308% | $7.86M-50.8% | -$5.38M-145% | ||
| $34.08M+3.9% | $40.45M+31.7% | $53.2M+135% | $38.67M+13.4% | $32.8M+2.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Lucid Diagnostics's total assets?
- Lucid Diagnostics (LUCD) holds $34.1M in total assets, up 3.9% year over year.
- How much debt does Lucid Diagnostics have?
- Lucid Diagnostics carries $1.6M in total debt against $4.0M of shareholders' equity, a debt-to-equity ratio of 0.40.
- How much cash does Lucid Diagnostics have?
- Lucid Diagnostics holds $27.9M in cash and equivalents.
- Can Lucid Diagnostics cover its short-term obligations?
- Its current ratio is 1.07 — current assets exceed current liabilities.
- Where does Lucid Diagnostics's balance sheet data come from?
- Every line is extracted from Lucid Diagnostics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
